Crossmark

LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI

Crossref DOI link: https://doi.org/10.1007/s11547-024-01879-8

Published Online: 2024-08-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agnello, Francesco

Cannella, Roberto

Brancatelli, Giuseppe

Galia, Massimo
License Information

Text and Data Mining valid from 2024-08-19

Version of Record valid from 2024-08-19
More Information

Article History

Received: 27 May 2023

Accepted: 12 August 2024

First Online: 19 August 2024

Declarations

:

: Francesco Agnello, Giuseppe Brancatelli and Massimo Galia declare they have no financial interests. Roberto Cannella has received travel support for attending meetings from Bracco and Bayer and co-funding by the European Union-FESR or FSE, PON Research and Innovation 2014-2020 - DM 1062/2021.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

: Institutional review board approval was obtained for this retrospective study with a waiver of the requirement for informed consent.

Document is current

Any future updates will be listed below